Inhibition of green tea polyphenol EGCG((−)-epigallocatechin-3-gallate) on the proliferation of gastric cancer cells by suppressing canonical wnt/β-catenin signalling pathway

References

• Bhatti SK, O’keefe JH, Lavie CJ. 2013. Coffee and tea: perks for health and longevity? Curr Opin Clin Nutrit Metab Care. 16:688–697.
   PubMed Web of Science ®Google Scholar
• Chen XF, Qian J, Pei D, Zhou C, Roe OD, Zhu F, He SH, Qian YY, Zhou Y, Xu J, et al. 2016. Prognostic value of perioperative leukocyte count in resectable gastric cancer. World J Gastroenterol. 22:2818–2827.
   PubMed Web of Science ®Google Scholar
• Clements WM, Wang J, Sarnaik A, Kim OJ, Macdonald J, Fenoglio-Preiser C, Groden J, Lowy AM. 2002. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 62:3503–3506.
   PubMed Web of Science ®Google Scholar
• Clevers H, Nusse R. 2012. Wnt/β-catenin signaling and disease. Cell. 149:1192–1205.
   PubMed Web of Science ®Google Scholar
• Crespy V, Williamson G. 2004. A review of the health effects of green tea catechins in in vivo animal models. J Nutr. 134:3431S–3440S.
   PubMed Web of Science ®Google Scholar
• Czyzewska J, Guzinska-Ustymowicz K, Ustymowicz M, Pryczynicz A, Kemona A. 2010. The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis. Folia Histochem Cytobiol. 48:37–45.
   PubMed Web of Science ®Google Scholar
• Dashwood WM, Carter O, Al-Fageeh M, Li Q, Dashwood RH. 2005. Lysosomal trafficking of beta-catenin induced by the tea polyphenol epigallocatechin-3-gallate. Mutat Res. 591:161–172.
   PubMed Web of Science ®Google Scholar
• Gough NR. 2012. Focus issue: Wnt and β-catenin signaling in development and disease. Sci Signal. 5:eg2.
   PubMed Web of Science ®Google Scholar
• Guo J, Fu Z, Wei J, Lu W, Feng J, Zhang S. 2015. PRRX1 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer. Med Oncol. 32:393.
   PubMed Web of Science ®Google Scholar
• Gwak J, Jung SJ, Kang DI, Kim EY, Kim DE, Chung YH, Shin JG, Oh S. 2009. Stimulation of protein kinase C-alpha suppresses colon cancer cell proliferation by down-regulation of beta-catenin. J Cell Mol Med. 13:2171–2180.
   PubMed Web of Science ®Google Scholar
• Han YM, Park JM, Jeong M, Yoo JH, Kim WH, Shin SP, Ko WJ, Hahm KB. 2015. Dietary, non-microbial intervention to prevent Helicobacter pylori-associated gastric diseases. Ann Transl Med. 3:122.
   PubMedGoogle Scholar
• Henning SM, Wang P, Carpenter CL, Heber D. 2013. Epigenetic effects of green tea polyphenols in cancer. Epigenomics. 5:729–741.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin. 61:69–90.
   PubMed Web of Science ®Google Scholar
• Jeong M, Park JM, Han YM, Kangwan N, Kwon SO, Kim BN, Kim WH, Hahm KB. 2016. Dietary intervention of artemisia and green tea extracts to rejuvenate Helicobacter pylori-associated chronic atrophic gastritis and to prevent tumorigenesis. Helicobacter. 21:40–59.
   PubMed Web of Science ®Google Scholar
• Jia S, Cai J. 2016. Update on biomarkers in development of anti-angiogenic drugs in gastric cancer. Anticancer Res. 36:1111–1118.
   PubMed Web of Science ®Google Scholar
• Kim J, Zhang X, Rieger-Christ KM, Summerhayes IC, Wazer DE, Paulson KE, Yee AS. 2006. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1. J Biol Chem. 281:10865–10875.
   PubMed Web of Science ®Google Scholar
• Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, et al. 2008. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 9:215–221.
   PubMed Web of Science ®Google Scholar
• Logan CY, Nusse R. 2004. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 20:781–810.
   PubMed Web of Science ®Google Scholar
• Nusse R. 2005. Wnt signaling in disease and in development. Cell Res. 15:28–32.
   PubMed Web of Science ®Google Scholar
• Ochoa-Hernandez AB, Juarez-Vazquez CI, Rosales-Reynoso MA, Barros-Nunez P. 2012. WNT-beta-catenin signaling pathway and its relationship with cancer. Cir Cir. 80:389–398.
   PubMedGoogle Scholar
• Ogunleye AA, Xue F, Michels KB. 2010. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat. 119:477–484.
   PubMed Web of Science ®Google Scholar
• Oh S, Gwak J, Park S, Yang CS. 2014. Green tea polyphenol EGCG suppresses Wnt/β-catenin signaling by promoting GSK-3β- and PP2A-independent β-catenin phosphorylation/degradation. Biofactors. 40:586–595.
   PubMed Web of Science ®Google Scholar
• Pan KF, Liu WG, Zhang L, You WC, Lu YY. 2008. Mutations in components of the Wnt signaling pathway in gastric cancer. World J Gastroenterol. 14:1570–1574.
   PubMed Web of Science ®Google Scholar
• Patel R, Ingle A, Maru GB. 2008. Polymeric black tea polyphenols inhibit 1,2-dimethylhydrazine induced colorectal carcinogenesis by inhibiting cell proliferation via Wnt/beta-catenin pathway. Toxicol Appl Pharmacol. 227:136–146.
   PubMed Web of Science ®Google Scholar
• Polakis P. 2012. Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 4:1–13.
   Web of Science ®Google Scholar
• Rahman R, Asombang AW, Ibdah JA. 2014. Characteristics of gastric cancer in Asia. World J Gastroenterol. 20:4483–4490.
   PubMed Web of Science ®Google Scholar
• Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T, Nashimoto A, Fujii M, Nakajima T, Ohashi Y. 2011. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 29:4387–4393.
   PubMed Web of Science ®Google Scholar
• Sereno M, De Castro J, Cejas P, Garcia-Cabezas MA, Belda C, Casado E, Feliu J, Gómez C, López M, Barón MG. 2012. Expression profile as predictor of relapse after adjuvant treatment in gastric cancer. J Gastrointest Cancer. 43:181–189.
   PubMedGoogle Scholar
• Sherwood V. 2015. WNT signaling: an emerging mediator of cancer cell metabolism? Mol Cell Biol. 35:2–10.
   PubMed Web of Science ®Google Scholar
• Shirakami Y, Shimizu M, Moriwaki H. 2012. Cancer chemoprevention with green tea catechins: from bench to bed. Curr Drug Targets. 13:1842–1857.
   PubMed Web of Science ®Google Scholar
• Singh BN, Shankar S, Srivastava RK. 2011. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol. 82:1807–1821.
   PubMed Web of Science ®Google Scholar
• Sugano K. 2015. Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 29:895–905.
   PubMed Web of Science ®Google Scholar
• Wodarz A, Nusse R. 1998. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol. 14:59–88.
   PubMed Web of Science ®Google Scholar
• Yang CS, Wang H. 2011a. Mechanistic issues concerning cancer prevention by tea catechins. Mol Nutr Food Res. 55:819–831.
   PubMed Web of Science ®Google Scholar
• Yang CS, Wang H, Li GX, Yang Z, Guan F, Jin H. 2011b. Cancer prevention by tea: evidence from laboratory studies. Pharmacol Res. 64:113–122.
   PubMed Web of Science ®Google Scholar
• Zhang H, Xue Y. 2008. Wnt pathway is involved in advanced gastric carcinoma. Hepatogastroenterology. 55:1126–1130.
   PubMed Web of Science ®Google Scholar
• Zou Y, Salinas P. 2014. Introduction: Wnt signaling mechanisms in development and disease. Dev Neurobiol. 74:757–758.
   PubMed Web of Science ®Google Scholar